Literature DB >> 1424054

Role of high density lipoproteins in the regression of atherosclerosis.

J J Badimon1, V Fuster, L Badimon.   

Abstract

Atherosclerosis is a slowly progressive disease characterized by the accumulation of cholesterol within the vessel wall. Plasma lipoproteins are particles of complex lipid and protein composition that transport lipids in blood. Low density lipoproteins (LDL) and high density lipoproteins (HDL) are the major cholesterol-carrier lipoproteins. LDL seem to be responsible for the delivery of lipids (cholesterol) from the liver to the tissues. Compelling evidence supports the concept that the lipids deposited in the arteriosclerotic lesions are derived primarily from plasma LDL. The term "reverse cholesterol transport" describes the transport of cholesterol from extrahepatic tissues to the liver, where it may be metabolized. Reverse cholesterol transport seems to be the major route for removal of the exchangeable cholesterol deposited in the extrahepatic tissue. It has been postulated that a major role of the plasma HDL particle is to act as a scavenger of tissue cholesterol. The hypothesis that high levels of plasma HDL are protective against coronary artery disease (CAD) was initially proposed by Barr et al in the early 1950s, but it was overlooked until confirmed by the Tromso and Framingham studies in 1977, which showed an inverse relation between HDL plasma levels and incidence of CAD. Similar observations have been made in 15 major experimental studies including eight countries.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424054

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Efficacy and safety of statins in hypercholesterolemia with emphasis on lipoproteins.

Authors:  San-Chiang Wu; Jeng-Chuan Shiang; Shoa-Lin Lin; Te-Lang Wu; Wei-Chun Huang; Kuan-Rau Chiou; Chun-Peng Liu
Journal:  Heart Vessels       Date:  2005-09       Impact factor: 2.037

Review 2.  Current, new and future treatments in dyslipidaemia and atherosclerosis.

Authors:  P H Chong; B S Bachenheimer
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

3.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux.

Authors:  Martin Gauster; Olga V Oskolkova; Josef Innerlohinger; Otto Glatter; Gabriele Knipping; Sasa Frank
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

5.  Endurance training enhances ABCA1 expression in rat small intestine.

Authors:  Behzad Mehdi Khabazian; Abbass Ghanbari-Niaki; Ali reza Safarzadeh-Golpordesari; Mehdi Ebrahimi; Fatemeh Rahbarizadeh; Hossein Abednazari
Journal:  Eur J Appl Physiol       Date:  2009-07-24       Impact factor: 3.078

6.  Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods.

Authors:  Bo Zhang; Eiso Shimoji; Hiroaki Tanaka; Keijiro Saku
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

7.  Regulated Inflammation and Lipid Metabolism in Colon mRNA Expressions of Obese Germfree Mice Responding to Enterobacter cloacae B29 Combined with the High Fat Diet.

Authors:  Huiying Yan; Na Fei; Guojun Wu; Chenhong Zhang; Liping Zhao; Menghui Zhang
Journal:  Front Microbiol       Date:  2016-11-08       Impact factor: 5.640

8.  Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression.

Authors:  Ioanna Vallianou; Margarita Hadzopoulou-Cladaras
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

9.  Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux.

Authors:  Sandhya Sankaranarayanan; John F Oram; Bela F Asztalos; Ashley M Vaughan; Sissel Lund-Katz; Maria Pia Adorni; Michael C Phillips; George H Rothblat
Journal:  J Lipid Res       Date:  2008-09-30       Impact factor: 5.922

10.  Effects and mechanism of Xin Mai Jia in a rabbit model of atherosclerosis.

Authors:  Fan-Rong Zhao; Jun-Xiu Lu; Mei Jia; Ya-Ling Yin; Heng-Tian Qi; Mo-Li Zhu; Li-Juan Ma; LE-LE Qiu; Guang-Ming Wan; Guang-Rui Wan
Journal:  Exp Ther Med       Date:  2015-09-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.